Literature DB >> 30343705

Geoepidemiology and (epi-)genetics in primary biliary cholangitis.

Roberto Rosa1, Laura Cristoferi1, Atsushi Tanaka2, Pietro Invernizzi3.   

Abstract

Primary biliary cholangitis (PBC) is a rare female preponderant chronic autoimmune cholestatic liver disease, characterized by intrahepatic ductopenia and progressive fibrosis. During last decades incidence and prevalence showed an increasing rate which vary widely worldwide demonstrating an important interaction between environmental and genetic factors. Heritability suggested by familial occurrence and monozygotic twins concordance have been confirmed in more studies. Epigenetics mechanisms such as histone modification and DNA methylation can partially explain predisposition and inheritance of this disease. Nevertheless, an association with specific class II human leukocyte antigen (HLA) variants have been reported, showing an increase risk in susceptibility. More recently, data regarding a strong protective association between PBC and HLA alleles confirmed this association. After recent genome-wide association studies (GWAS), a more intricate interaction between PBC and the HLA region has been shown. Furthermore, GWAS also identified several immune-related-genes implicated. More genome-wide association studies on this disease are needed to reach a complete and systematic knowledge of this disease. In this review we discuss more recent issued data on geoepidemiology of PBC and the role of (epi-)genetic mechanisms in its pathogenesis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epigenetics; Genetics; Geoepidemiology; Human leukocyte antigen; Primary biliary cholangitis; X-chromosome monosomy

Mesh:

Year:  2018        PMID: 30343705     DOI: 10.1016/j.bpg.2018.05.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  4 in total

1.  Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study.

Authors:  Kosuke Matsumoto; Satoko Ohfuji; Masanori Abe; Atsumasa Komori; Atsushi Takahashi; Hideki Fujii; Kazuhito Kawata; Hidenao Noritake; Tomoko Tadokoro; Akira Honda; Maiko Asami; Tadashi Namisaki; Masayuki Ueno; Ken Sato; Keisuke Kakisaka; Mie Arakawa; Takanori Ito; Kazunari Tanaka; Takeshi Matsui; Toru Setsu; Masaaki Takamura; Satoshi Yasuda; Tomohiro Katsumi; Jun Itakura; Tomoya Sano; Yamato Tamura; Ryo Miura; Toshihiko Arizumi; Yoshinari Asaoka; Kiyoko Uno; Ai Nishitani; Yoshiyuki Ueno; Shuji Terai; Yasuhiro Takikawa; Youichi Morimoto; Hitoshi Yoshiji; Satoshi Mochida; Tadashi Ikegami; Tsutomu Masaki; Norifumi Kawada; Hiromasa Ohira; Atsushi Tanaka
Journal:  J Gastroenterol       Date:  2021-11-18       Impact factor: 7.527

2.  Genetic association of E26 transformation specific sequence 1 polymorphisms with the susceptibility of primary biliary cholangitis in China.

Authors:  Huan Xu; Qian Niu; Zhenzhen Su; Fang Wang; Junlong Zhang; Bin Yang; Zhuochun Huang
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

Review 3.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

4.  The Causal Effects of Primary Biliary Cholangitis on Thyroid Dysfunction: A Two-Sample Mendelian Randomization Study.

Authors:  Peng Huang; Yuqing Hou; Yixin Zou; Xiangyu Ye; Rongbin Yu; Sheng Yang
Journal:  Front Genet       Date:  2021-12-10       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.